Literature DB >> 17577676

A comparative evaluation of Tl-201 and Tc-99m sestamibi myocardial perfusion spect imaging in diabetic patients.

Ozgür Omür1, Zehra Ozcan, Murat Argon, Ebru Tani Acar.   

Abstract

AIM: Myocardial perfusion scintigraphy (MPS) is an effective tool for early diagnosis of coronary artery disease (CAD) in type II diabetes mellitus (DM). The purpose of this study was to review the comparative findings of Tc-99m MIBI and Tl-201 MPS in defining normal and abnormal myocardial segments, type and extent of the perfusion defects with reference to coronary angiography findings in diabetic patients.
METHODS: Thirty patients with type II DM who had abnormal Tc-99m MIBI MPS findings and underwent coronary angiography were included this study (20 male, 10 female; mean age was 64 +/- 11 years). Those patients were also investigated with Tl-201 MPS thereafter. All scintigraphic images were evaluated semiquantitatively using a 20-segments myocardial model. The perfusion of myocardial segments, reversibility and severity of defects based on defect score were compared using the MIBI and Tl-201 images in relation to coronary angiography. Diffuse slow-washout of Tl-201 was also noted.
RESULTS: A total of 600 myocardial segments were comparatively analyzed. Diagnostic concordance between both tracers in defining normal and abnormal perfusion on a segmental basis was 88% (kappa = 0.71). The percentage of normal, reversible and non-reversible segments in the Tc-99m MIBI and Tl-201 study were 67-61%, 11-20% and 22-19% respectively. While the number of irreversible defects were similar for both tracers, more number of reversible defects were identified by Tl-201 MPS than Tc-99m MIBI (65 vs. 123, p = 0.001). No significant difference between the defect scores of both tracers was found.
CONCLUSION: MPS using both tracers offered agreement in defining or excluding perfusion abnormalities in a major part of the data. However, Tl-201 MPS yielded better detection rate of myocardial ischemia than Tc-99m MIBI MPS in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17577676     DOI: 10.1007/s10554-007-9244-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  28 in total

1.  The higher likelihood of developing cardiomegaly during follow-up in patients with syndrome X and abnormal thallium-201 myocardial perfusion SPECT.

Authors:  S S Sun; J L Huang; S C Tsai; Y J Ho; C H Kao
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

2.  Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus.

Authors:  X Kang; D S Berman; H Lewin; R Miranda; J Erel; J D Friedman; A M Amanullah
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

Review 3.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

4.  Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease.

Authors:  J K Kahn; I McGhie; M S Akers; M N Sills; T L Faber; P V Kulkarni; J T Willerson; J R Corbett
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

5.  Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease.

Authors:  I Yokoyama; K Yonekura; T Ohtake; W Yang; W S Shin; N Yamada; K Ohtomo; R Nagai
Journal:  J Nucl Med       Date:  2000-06       Impact factor: 10.057

6.  A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST study.

Authors:  Akhil Kapur; Katherine A Latus; Glyn Davies; Rhanju T Dhawan; Sian Eastick; Peter H Jarritt; George Roussakis; Melanie C Young; Constantinos Anagnostopoulos; Jimmy Bomanji; Durval C Costa; Dudley J Pennell; Elizabeth M Prvulovich; Peter J Ell; S Richard Underwood
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-10-11       Impact factor: 9.236

7.  Silent myocardial ischemia in patients with diabetes: who to screen.

Authors:  B Janand-Delenne; B Savin; G Habib; M Bory; P Vague; V Lassmann-Vague
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

8.  [Significance of diffuse slow washout in dipyridamole loading thallium-201 myocardial perfusion scintigraphy].

Authors:  Y Yonezawa; N Hamashige; Y Doi; T Ozawa; H Odawara; J Takata; M Yamada; N Akagi; T Maeda; S Yoshida
Journal:  Kaku Igaku       Date:  1991-04

9.  Comments to: Clinical Comparison Between Thallium 201 and Tc-99m-Methoxy Isobutyl Isonitrile (Hexamibi) Myocardial Perfusion Imaging for Detection of Coronary Artery Disease.

Authors:  D R Whalley
Journal:  Eur J Nucl Med       Date:  1989

Review 10.  Comparison of thallium-201 and technetium-99m methoxyisobutyl isonitrile.

Authors:  F J Wackers
Journal:  Am J Cardiol       Date:  1992-11-05       Impact factor: 2.778

View more
  2 in total

1.  Myocardial perfusion defects and coronary risk factors in symptomatic and asymptomatic elderly women.

Authors:  Su Jin Lee; Kyung-Han Lee; So-Mi Park; Eun Jeong Lee; Hyun Woo Chung; Young Seok Cho; Joon Young Choi; Byung-Tae Kim
Journal:  Int J Cardiovasc Imaging       Date:  2007-09-05       Impact factor: 2.357

2.  What is the best myocardial perfusion protocol in diabetic patients?

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2007-09-01       Impact factor: 2.357

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.